Schonfeld Strategic Advisors LLC Fibrogen Inc Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 49,200 shares of FGEN stock, worth $17,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,200
Previous 39,500
24.56%
Holding current value
$17,220
Previous $92,000
53.26%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding FGEN
# of Institutions
113Shares Held
57.5MCall Options Held
2.14MPut Options Held
907K-
Primecap Management CO Pasadena, CA13.7MShares$4.78 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY8.94MShares$3.13 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$2.06 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.36MShares$1.18 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$843,3770.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $32.8M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...